1. Home
  2. ARBE vs VRCA Comparison

ARBE vs VRCA Comparison

Compare ARBE & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbe Robotics Ltd.

ARBE

Arbe Robotics Ltd.

N/A

Current Price

$0.66

Market Cap

79.1M

Sector

Technology

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

N/A

Current Price

$5.69

Market Cap

88.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARBE
VRCA
Founded
2015
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.1M
88.0M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
ARBE
VRCA
Price
$0.66
$5.69
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$2.38
$17.00
AVG Volume (30 Days)
959.3K
82.4K
Earning Date
05-19-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$35,577,000.00
Revenue This Year
$363.94
N/A
Revenue Next Year
$286.43
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
370.22
52 Week Low
$0.55
$3.28
52 Week High
$2.88
$9.82

Technical Indicators

Market Signals
Indicator
ARBE
VRCA
Relative Strength Index (RSI) 40.83 47.63
Support Level $0.65 $4.25
Resistance Level $0.90 $6.67
Average True Range (ATR) 0.04 0.40
MACD -0.01 0.04
Stochastic Oscillator 4.58 37.50

Price Performance

Historical Comparison
ARBE
VRCA

About ARBE Arbe Robotics Ltd.

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: